Business
Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways
Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways.
About this update from Branded Legacy Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways\r\n \r\n \r\n\r\n\r\nBranded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways\r\nAcquisition Poised to Accelerate Life-Saving Interventions, Combining Academic Excellence with Real-World Innovation to Address Global Addiction Crises and Unlock Multi-Billion Market Opportunities\r\n\r\n\r\n\r\n\r\n\r\nVANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a leading diversified holdings company dedicated to pioneering health and wellness solutions, today announced a groundbreaking strategic partnership between its wholly-owned subsidiary, Bio-Legacy Evaluative Group, and McMaster University, one of the world's top medical universities renowned for its influential research in addiction medicine, clinical trials, and guideline development at state, provincial, national, and international levels. This collaboration will focus on evaluating Bio-Legacy Evaluative Group's innovative products for populations affected by addictions, leveraging McMaster's expertise in groundbreaking research and its access to world leaders in the field. The partnership unites the clinical research prowess of McMaster University with the real-world experience of Bio-Legacy Evaluative Group's scientists in addictions medicine, paving the way for rigorous evaluations, multiple clinical trials, and regulatory submissions for Bio-Legacy Evaluative Group's drug devices and new compounds. This alliance is set to drive the development of accessible, cost-effective interventions that address acute overdose deaths, minimize drug-related harms, and support long-term recovery for addicted populations. Professor Ed Mills of McMaster University commented, \"The collaboration between Bio-Legacy Evaluative Group and the faculty here allows us to further our deep commitment to addressing the needs for treatments in addictions and the rigorous evaluations of interventions that can save lives. In addition to the many clinical research projects at McMaster University and the enormous populations we work with that are affected by addictio...